Publications : Spending

Letters 

NTU Praises New Bills That Would Make Health Care More Personal and Portable

by Andrew Lautz January 21, 2020

Blog 

Importing Single Payer Style Price Controls Is Not the Way to Lower U.S. Drug Costs

by Andrew Lautz December 19, 2019

Vote Alert 

Lawmakers Should Oppose the Nearly $1.4-Trillion Budget Deal

by Andrew Lautz December 17, 2019

Op-Ed 

‘Surprise Billing’ Solution Proposal Won’t Work — We Have Proof

by Pete Sepp December 13, 2019

Op-Ed 

We Hate Surprise Bills. Why Should we Accept one From Congress?

by Andrew Lautz December 13, 2019

Letters 

Congress Should Not Reduce Incentives for Generic Drug Competition

by Andrew Lautz December 12, 2019

Blog 

New Drug Pricing Bill Offers Several Promising Bipartisan Ideas

by Andrew Lautz December 11, 2019

Letters 

Coalition Urges Congress to Avoid Jamming Last-Minute Surprise Billing Deal Into Year-End Legislation

by Andrew Lautz December 11, 2019

Vote Alert 

Representatives Should Vote No on H.R. 3, the Pelosi Drug Pricing Plan

by Andrew Lautz December 10, 2019

Press Release 

“Surprise Billing” Health Legislation Would Insert Federal Bureaucrats Into Health Decisions

December 09, 2019

Blog 

Generic Drugs Save Taxpayers and Patients Money. Congress Could Accidentally Hurt Them This Month.

by Andrew Lautz December 09, 2019

Letters 

NTU Identifies Pro-Taxpayer Amendments for Pelosi Drug Pricing Bill

by Andrew Lautz December 09, 2019

Op-Ed 

Congress Ripping Up Its Wish List Would Make For A Merry Christmas

by Mattie Duppler December 06, 2019

Blog 

Some Generic Drugs Are Not Making It Onto Part D Formularies. A New Bill Could Fix That.

by Andrew Lautz November 22, 2019